Page last updated: 2024-09-05

opc 28326 and Ischemia

opc 28326 has been researched along with Ischemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hashimoto, A; Imaizumi, T; Mori, T; Nagai, R; Ohki, T; Sata, M; Sumi, M; Yanaga, K	1

Other Studies

1 other study(ies) available for opc 28326 and Ischemia

Article	Year
OPC-28326, a selective femoral arterial vasodilator, augments ischemia induced angiogenesis. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2007, Volume: 61, Issue:4 Topics: Aniline Compounds; Animals; Aorta; Blotting, Western; Cells, Cultured; Dose-Response Relationship, Drug; Endothelial Cells; Endothelium, Vascular; Hindlimb; Humans; In Vitro Techniques; Ischemia; Laser-Doppler Flowmetry; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Neovascularization, Physiologic; Nitric Oxide Synthase Type III; Phosphorylation; Piperidines; Rats; Regional Blood Flow; Vasodilator Agents	2007

Article

Year

OPC-28326, a selective femoral arterial vasodilator, augments ischemia induced angiogenesis.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2007, Volume: 61, Issue:4

Topics: Aniline Compounds; Animals; Aorta; Blotting, Western; Cells, Cultured; Dose-Response Relationship, Drug; Endothelial Cells; Endothelium, Vascular; Hindlimb; Humans; In Vitro Techniques; Ischemia; Laser-Doppler Flowmetry; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Neovascularization, Physiologic; Nitric Oxide Synthase Type III; Phosphorylation; Piperidines; Rats; Regional Blood Flow; Vasodilator Agents

2007